KPIs & Operating Metrics(New)
Balance Sheet
AssetsCash & Current InvestmentsCommon EquityCurrent Deferred RevenueGoodwillGoodwill & IntangiblesLiabilities and Shareholders EquityLiabilities from Discontinued OperationsLong-Term Deferred TaxLong-Term InvestmentsMinority InterestNon-Current Deferred Tax LiabilityOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPensionPreferred SharesProperty, Plant & Equipment (Net)ReceivablesReceivables - AccuredRetained EarningsSecurities - TradableShareholder's EquityShort-term InvestmentsTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Allstate (ALL) Other Accumulated Expenses (2016 - 2025)

Allstate (ALL) has disclosed Other Accumulated Expenses for 15 consecutive years, with $43.1 billion as the latest value for Q3 2025.

  • On a quarterly basis, Other Accumulated Expenses rose 0.84% to $43.1 billion in Q3 2025 year-over-year; TTM through Sep 2025 was $43.1 billion, a 0.84% increase, with the full-year FY2024 number at $41.9 billion, up 5.17% from a year prior.
  • Other Accumulated Expenses was $43.1 billion for Q3 2025 at Allstate, down from $43.8 billion in the prior quarter.
  • In the past five years, Other Accumulated Expenses ranged from a high of $43.8 billion in Q1 2025 to a low of $31.4 billion in Q1 2021.
  • A 5-year average of $38.0 billion and a median of $39.3 billion in 2023 define the central range for Other Accumulated Expenses.
  • Peak YoY movement for Other Accumulated Expenses: rose 19.74% in 2021, then grew 0.84% in 2025.
  • Allstate's Other Accumulated Expenses stood at $33.1 billion in 2021, then rose by 13.55% to $37.5 billion in 2022, then grew by 6.17% to $39.9 billion in 2023, then grew by 5.17% to $41.9 billion in 2024, then grew by 2.83% to $43.1 billion in 2025.
  • Per Business Quant, the three most recent readings for ALL's Other Accumulated Expenses are $43.1 billion (Q3 2025), $43.8 billion (Q1 2025), and $41.9 billion (Q4 2024).